TEV-56286 for multiple system atrophy

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Phase 2 trial. Mid-stage trial in people. As of 19 Nov 2026, from 2 registered trials.

Why this status

  1. 23 Aug 2024: Trial registered, NCT06568237
  2. 2 Oct 2024: Trial started, NCT06568237
  3. 29 Sep 2025: Trial registered, NCT07197866
  4. 30 Sep 2025: Trial started, NCT07197866

The trials

NCT06568237: A Trial to Test if TEV-56286 is Effective for Treatment of Participants With Multiple System Atrophy

State
Under way
Phase
Phase 2
People
349 taking part
Started
2 Oct 2024
Primary completion
15 Sep 2027
Arms
TEV-56286
Results
None posted
  1. 23 Aug 2024: Trial registered
  2. 2 Oct 2024: Trial started

NCT07197866: An Extension Trial to Test if TEV-56286 is Effective in Relieving Multiple System Atrophy

State
Under way
Phase
Phase 2
People
200 planned
Started
30 Sep 2025
Primary completion
3 May 2029
Arms
TEV-56286
Results
None posted
  1. 29 Sep 2025: Trial registered
  2. 30 Sep 2025: Trial started

How the status changed

  1. 19 Nov 2026: First set: Phase 2 trial

About the treatment

Kind of treatment: Drug.

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.